New pill could ease lupus skin flares in major trial

NCT ID NCT07332481

First seen Jan 12, 2026 · Last updated May 14, 2026 · Updated 18 times

Summary

This study tests a new pill, enpatoran, for people with lupus who have active skin rashes. About 202 participants will receive either the drug or a placebo for 24 weeks, while continuing their usual treatments. The goal is to see if enpatoran can reduce skin disease severity and improve overall lupus control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Allen Arthritis

    RECRUITING

    Allen, Texas, 75013, United States

  • Arthritis and Rheumatology Research Institute PLLC

    RECRUITING

    Allen, Texas, 75013, United States

  • Dermatology Research Associates - 300204025

    RECRUITING

    Los Angeles, California, 90045, United States

  • Emory University School of Medicine

    RECRUITING

    Atlanta, Georgia, 30303, United States

  • Revival Research Institute, LLC

    RECRUITING

    Troy, Michigan, 48084, United States

Conditions

Explore the condition pages connected to this study.